Multimodal biomedical AI

JN Acosta, GJ Falcone, P Rajpurkar, EJ Topol - Nature Medicine, 2022 - nature.com
The increasing availability of biomedical data from large biobanks, electronic health records,
medical imaging, wearable and ambient biosensors, and the lower cost of genome and …

Barriers and facilitators of the uptake of digital health technology in cardiovascular care: a systematic sco** review

S Whitelaw, DM Pellegrini, MA Mamas… - … Heart Journal-Digital …, 2021 - academic.oup.com
Digital health technology (DHT) has the potential to revolutionize healthcare delivery but its
uptake has been low in clinical and research settings. The factors that contribute to the …

Digital approaches to enhancing community engagement in clinical trials

RKJ Tan, D Wu, S Day, Y Zhao, HJ Larson… - NPJ digital …, 2022 - nature.com
Digital approaches are increasingly common in clinical trial recruitment, retention, analysis,
and dissemination. Community engagement processes have contributed to the successful …

Artificial intelligence and machine learning for clinical pharmacology

DK Ryan, RH Maclean, A Balston… - British Journal of …, 2024 - Wiley Online Library
Artificial intelligence (AI) will impact many aspects of clinical pharmacology, including drug
discovery and development, clinical trials, personalized medicine, pharmacogenomics …

Toward precision medicine: circadian rhythm of blood pressure and chronotherapy for hypertension-2021 NHLBI workshop report

ML Gumz, D Shimbo, M Abdalla, RC Balijepalli… - …, 2023 - Am Heart Assoc
Healthy individuals exhibit blood pressure variation over a 24-hour period with higher blood
pressure during wakefulness and lower blood pressure during sleep. Loss or disruption of …

The need for increased pragmatism in cardiovascular clinical trials

MS Usman, HGC Van Spall, SJ Greene… - Nature Reviews …, 2022 - nature.com
The majority of cardiovascular randomized controlled trials (RCTs) test interventions in
selected patient populations under explicitly protocol-defined settings. Although these …

[HTML][HTML] Decentralised clinical trials: ethical opportunities and challenges

E Vayena, A Blasimme, J Sugarman - The Lancet Digital Health, 2023 - thelancet.com
Fuelled by adaptations to clinical trial implementation during the COVID-19 pandemic,
decentralised clinical trials are burgeoning. Decentralised clinical trials involve many digital …

Implementation of digital health technology in clinical trials: the 6R framework

CO Durán, M Bonam, E Björk, R Hughes, S Ghiorghiu… - Nature Medicine, 2023 - nature.com
Implementation of digital health technology in clinical trials: the 6R framework | Nature Medicine
Skip to main content Thank you for visiting nature.com. You are using a browser version with …

Participation of Black Americans in cancer clinical trials: current challenges and proposed solutions

M Awidi, S Al Hadidi - JCO Oncology Practice, 2021 - ascopubs.org
Low participation of Black Americans in cancer clinical trials is a well-established
predicament. Many factors resulted in this current dilemma with racism being the …

Clinical trials of immunotherapy in triple-negative breast cancer

FM Howard, AT Pearson, R Nanda - Breast Cancer Research and …, 2022 - Springer
Purpose Immunotherapy has started to transform the treatment of triple-negative breast
cancer (TNBC), in part due to the unique immunogenicity of this breast cancer subtype. This …